Loading…
Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production
The potential to induce systemic tolerance following exposure of the airway mucosa to soluble antigen, may be applied therapeutically for the treatment of allergic disease. Since the use of allergen can trigger IgE mediated inflammation, we investigated whether mucosal delivery of a peptide, contain...
Saved in:
Published in: | Vaccine 2003-01, Vol.21 (5), p.549-561 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c549t-3713efe42013cef6a2ad67d2f6bbede0dd09985638bf44d6c0fc25c167abb1f13 |
---|---|
cites | cdi_FETCH-LOGICAL-c549t-3713efe42013cef6a2ad67d2f6bbede0dd09985638bf44d6c0fc25c167abb1f13 |
container_end_page | 561 |
container_issue | 5 |
container_start_page | 549 |
container_title | Vaccine |
container_volume | 21 |
creator | Hall, Gillian Houghton, Christian G. Rahbek, Janne Uldal Lamb, Jonathan R. Jarman, Elizabeth R. |
description | The potential to induce systemic tolerance following exposure of the airway mucosa to soluble antigen, may be applied therapeutically for the treatment of allergic disease. Since the use of allergen can trigger IgE mediated inflammation, we investigated whether mucosal delivery of a peptide, containing an immunodominant epitope of the Der p1 allergen of house dust mite, can lead to CD4
+ Th2 cell tolerance and thus protect against airway inflammatory responses to inhalant allergen. The administration of microencapsulated peptide to the nasal mucosa of mice, protected against airway inflammation, with significant reductions in eosinophil infiltration into the airways following allergen challenge. Der p1 specific antibody levels in sera were not modulated. Allergen reactive CD4
+ T cells expressed a tolerized phenotype, with reduction in levels of the cytokines, IL-5, IL-13 and IFN-γ although IL-10 levels were increased. The mucosal administration of a peptide containing an immunodominant region of an allergen can protect against the induction of systemic and local inflammatory responses to allergen challenge. |
doi_str_mv | 10.1016/S0264-410X(02)00394-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72977174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X02003948</els_id><sourcerecordid>3187691551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-3713efe42013cef6a2ad67d2f6bbede0dd09985638bf44d6c0fc25c167abb1f13</originalsourceid><addsrcrecordid>eNqFkstu1TAURSMEopfCJ4AsIVAZBI4dP5IRQhWPSldi0CIxsxz7hLokdmonlfpLfCW-7YVKDOjIr3X2TrR3VT2n8JYCle9OgUlecwrfj4C9AWg6XrcPqg1tVVMzQduH1eYvclA9yfkCAERDu8fVAWVlI4XYVL9O13lOmLOPgcSBmHHE9AMDSWjs4q-QnJ0zMqHzZkFXbvMcQ8ZMTHBkXscpBpOuCcbsQ5zP_egN6a-JD0sywWQzEuMmH3wu5-WPRyB-mtYQXSxPJixkxnnxDonPZPThZzFaIjnZ1hTInKJb7W70afVoMGPGZ_v1sPr26ePZ8Zd6-_XzyfGHbW0F75a6UbTBATkD2lgcpGHGSeXYIPseHYJz0HWtkE3bD5w7aWGwTFgqlel7OtDmsHp9q1usL1fMi558tjiOJmBcs1asU4oqfi9IWylFK5oCHv0fFABKSdXtNF_-g17ENYXyv5ryDrpifiMobimbYs4JBz0nP5UgNAW9q4e-qYfeZa-B6Zt66LbMvdirr33J9G5q34cCvNoDJlszDiVE6_Mdx3nLBIfCvb_lsARx5THpbD0GW3qS0C7aRX_Pp_wGBYDahg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490972953</pqid></control><display><type>article</type><title>Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Hall, Gillian ; Houghton, Christian G. ; Rahbek, Janne Uldal ; Lamb, Jonathan R. ; Jarman, Elizabeth R.</creator><creatorcontrib>Hall, Gillian ; Houghton, Christian G. ; Rahbek, Janne Uldal ; Lamb, Jonathan R. ; Jarman, Elizabeth R.</creatorcontrib><description>The potential to induce systemic tolerance following exposure of the airway mucosa to soluble antigen, may be applied therapeutically for the treatment of allergic disease. Since the use of allergen can trigger IgE mediated inflammation, we investigated whether mucosal delivery of a peptide, containing an immunodominant epitope of the Der p1 allergen of house dust mite, can lead to CD4
+ Th2 cell tolerance and thus protect against airway inflammatory responses to inhalant allergen. The administration of microencapsulated peptide to the nasal mucosa of mice, protected against airway inflammation, with significant reductions in eosinophil infiltration into the airways following allergen challenge. Der p1 specific antibody levels in sera were not modulated. Allergen reactive CD4
+ T cells expressed a tolerized phenotype, with reduction in levels of the cytokines, IL-5, IL-13 and IFN-γ although IL-10 levels were increased. The mucosal administration of a peptide containing an immunodominant region of an allergen can protect against the induction of systemic and local inflammatory responses to allergen challenge.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(02)00394-8</identifier><identifier>PMID: 12531655</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Allergens ; Allergens - immunology ; Allergies ; Allergy ; Animals ; Asthma - pathology ; Biological and medical sciences ; Biotechnology ; Bronchoalveolar Lavage Fluid - cytology ; Cloning ; Dermatophagoides farinae - immunology ; Dermatophagoides pteronyssinus ; Eosinophils - immunology ; Fundamental and applied biological sciences. Psychology ; Health. Pharmaceutical industry ; House dust ; Immune Tolerance - immunology ; Immunity, Cellular - immunology ; Immunization ; Immunodominant Epitopes - immunology ; Immunoregulation ; In vivo animal models ; Industrial applications and implications. Economical aspects ; Interleukin-10 - biosynthesis ; Interleukin-13 - biosynthesis ; Interleukin-4 - biosynthesis ; Interleukin-5 - biosynthesis ; Leukocyte Count ; Lung - cytology ; Lymphocytes ; Mice ; Mice, Inbred C57BL ; Microencapsulated antigen ; Peptides ; Peptides - immunology ; Population ; Production of active biomolecules ; Pulmonary Eosinophilia - immunology ; Pulmonary Eosinophilia - metabolism ; Pulmonary Eosinophilia - prevention & control ; Rodents ; Studies ; Th1 Cells - immunology ; Th2 Cells - immunology ; Vaccins</subject><ispartof>Vaccine, 2003-01, Vol.21 (5), p.549-561</ispartof><rights>2002</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 17, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-3713efe42013cef6a2ad67d2f6bbede0dd09985638bf44d6c0fc25c167abb1f13</citedby><cites>FETCH-LOGICAL-c549t-3713efe42013cef6a2ad67d2f6bbede0dd09985638bf44d6c0fc25c167abb1f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14482540$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12531655$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hall, Gillian</creatorcontrib><creatorcontrib>Houghton, Christian G.</creatorcontrib><creatorcontrib>Rahbek, Janne Uldal</creatorcontrib><creatorcontrib>Lamb, Jonathan R.</creatorcontrib><creatorcontrib>Jarman, Elizabeth R.</creatorcontrib><title>Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>The potential to induce systemic tolerance following exposure of the airway mucosa to soluble antigen, may be applied therapeutically for the treatment of allergic disease. Since the use of allergen can trigger IgE mediated inflammation, we investigated whether mucosal delivery of a peptide, containing an immunodominant epitope of the Der p1 allergen of house dust mite, can lead to CD4
+ Th2 cell tolerance and thus protect against airway inflammatory responses to inhalant allergen. The administration of microencapsulated peptide to the nasal mucosa of mice, protected against airway inflammation, with significant reductions in eosinophil infiltration into the airways following allergen challenge. Der p1 specific antibody levels in sera were not modulated. Allergen reactive CD4
+ T cells expressed a tolerized phenotype, with reduction in levels of the cytokines, IL-5, IL-13 and IFN-γ although IL-10 levels were increased. The mucosal administration of a peptide containing an immunodominant region of an allergen can protect against the induction of systemic and local inflammatory responses to allergen challenge.</description><subject>Allergens</subject><subject>Allergens - immunology</subject><subject>Allergies</subject><subject>Allergy</subject><subject>Animals</subject><subject>Asthma - pathology</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Bronchoalveolar Lavage Fluid - cytology</subject><subject>Cloning</subject><subject>Dermatophagoides farinae - immunology</subject><subject>Dermatophagoides pteronyssinus</subject><subject>Eosinophils - immunology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Health. Pharmaceutical industry</subject><subject>House dust</subject><subject>Immune Tolerance - immunology</subject><subject>Immunity, Cellular - immunology</subject><subject>Immunization</subject><subject>Immunodominant Epitopes - immunology</subject><subject>Immunoregulation</subject><subject>In vivo animal models</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Interleukin-10 - biosynthesis</subject><subject>Interleukin-13 - biosynthesis</subject><subject>Interleukin-4 - biosynthesis</subject><subject>Interleukin-5 - biosynthesis</subject><subject>Leukocyte Count</subject><subject>Lung - cytology</subject><subject>Lymphocytes</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microencapsulated antigen</subject><subject>Peptides</subject><subject>Peptides - immunology</subject><subject>Population</subject><subject>Production of active biomolecules</subject><subject>Pulmonary Eosinophilia - immunology</subject><subject>Pulmonary Eosinophilia - metabolism</subject><subject>Pulmonary Eosinophilia - prevention & control</subject><subject>Rodents</subject><subject>Studies</subject><subject>Th1 Cells - immunology</subject><subject>Th2 Cells - immunology</subject><subject>Vaccins</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkstu1TAURSMEopfCJ4AsIVAZBI4dP5IRQhWPSldi0CIxsxz7hLokdmonlfpLfCW-7YVKDOjIr3X2TrR3VT2n8JYCle9OgUlecwrfj4C9AWg6XrcPqg1tVVMzQduH1eYvclA9yfkCAERDu8fVAWVlI4XYVL9O13lOmLOPgcSBmHHE9AMDSWjs4q-QnJ0zMqHzZkFXbvMcQ8ZMTHBkXscpBpOuCcbsQ5zP_egN6a-JD0sywWQzEuMmH3wu5-WPRyB-mtYQXSxPJixkxnnxDonPZPThZzFaIjnZ1hTInKJb7W70afVoMGPGZ_v1sPr26ePZ8Zd6-_XzyfGHbW0F75a6UbTBATkD2lgcpGHGSeXYIPseHYJz0HWtkE3bD5w7aWGwTFgqlel7OtDmsHp9q1usL1fMi558tjiOJmBcs1asU4oqfi9IWylFK5oCHv0fFABKSdXtNF_-g17ENYXyv5ryDrpifiMobimbYs4JBz0nP5UgNAW9q4e-qYfeZa-B6Zt66LbMvdirr33J9G5q34cCvNoDJlszDiVE6_Mdx3nLBIfCvb_lsARx5THpbD0GW3qS0C7aRX_Pp_wGBYDahg</recordid><startdate>20030117</startdate><enddate>20030117</enddate><creator>Hall, Gillian</creator><creator>Houghton, Christian G.</creator><creator>Rahbek, Janne Uldal</creator><creator>Lamb, Jonathan R.</creator><creator>Jarman, Elizabeth R.</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20030117</creationdate><title>Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production</title><author>Hall, Gillian ; Houghton, Christian G. ; Rahbek, Janne Uldal ; Lamb, Jonathan R. ; Jarman, Elizabeth R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-3713efe42013cef6a2ad67d2f6bbede0dd09985638bf44d6c0fc25c167abb1f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Allergens</topic><topic>Allergens - immunology</topic><topic>Allergies</topic><topic>Allergy</topic><topic>Animals</topic><topic>Asthma - pathology</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Bronchoalveolar Lavage Fluid - cytology</topic><topic>Cloning</topic><topic>Dermatophagoides farinae - immunology</topic><topic>Dermatophagoides pteronyssinus</topic><topic>Eosinophils - immunology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Health. Pharmaceutical industry</topic><topic>House dust</topic><topic>Immune Tolerance - immunology</topic><topic>Immunity, Cellular - immunology</topic><topic>Immunization</topic><topic>Immunodominant Epitopes - immunology</topic><topic>Immunoregulation</topic><topic>In vivo animal models</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Interleukin-10 - biosynthesis</topic><topic>Interleukin-13 - biosynthesis</topic><topic>Interleukin-4 - biosynthesis</topic><topic>Interleukin-5 - biosynthesis</topic><topic>Leukocyte Count</topic><topic>Lung - cytology</topic><topic>Lymphocytes</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microencapsulated antigen</topic><topic>Peptides</topic><topic>Peptides - immunology</topic><topic>Population</topic><topic>Production of active biomolecules</topic><topic>Pulmonary Eosinophilia - immunology</topic><topic>Pulmonary Eosinophilia - metabolism</topic><topic>Pulmonary Eosinophilia - prevention & control</topic><topic>Rodents</topic><topic>Studies</topic><topic>Th1 Cells - immunology</topic><topic>Th2 Cells - immunology</topic><topic>Vaccins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hall, Gillian</creatorcontrib><creatorcontrib>Houghton, Christian G.</creatorcontrib><creatorcontrib>Rahbek, Janne Uldal</creatorcontrib><creatorcontrib>Lamb, Jonathan R.</creatorcontrib><creatorcontrib>Jarman, Elizabeth R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hall, Gillian</au><au>Houghton, Christian G.</au><au>Rahbek, Janne Uldal</au><au>Lamb, Jonathan R.</au><au>Jarman, Elizabeth R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2003-01-17</date><risdate>2003</risdate><volume>21</volume><issue>5</issue><spage>549</spage><epage>561</epage><pages>549-561</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>The potential to induce systemic tolerance following exposure of the airway mucosa to soluble antigen, may be applied therapeutically for the treatment of allergic disease. Since the use of allergen can trigger IgE mediated inflammation, we investigated whether mucosal delivery of a peptide, containing an immunodominant epitope of the Der p1 allergen of house dust mite, can lead to CD4
+ Th2 cell tolerance and thus protect against airway inflammatory responses to inhalant allergen. The administration of microencapsulated peptide to the nasal mucosa of mice, protected against airway inflammation, with significant reductions in eosinophil infiltration into the airways following allergen challenge. Der p1 specific antibody levels in sera were not modulated. Allergen reactive CD4
+ T cells expressed a tolerized phenotype, with reduction in levels of the cytokines, IL-5, IL-13 and IFN-γ although IL-10 levels were increased. The mucosal administration of a peptide containing an immunodominant region of an allergen can protect against the induction of systemic and local inflammatory responses to allergen challenge.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12531655</pmid><doi>10.1016/S0264-410X(02)00394-8</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2003-01, Vol.21 (5), p.549-561 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_72977174 |
source | Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list) |
subjects | Allergens Allergens - immunology Allergies Allergy Animals Asthma - pathology Biological and medical sciences Biotechnology Bronchoalveolar Lavage Fluid - cytology Cloning Dermatophagoides farinae - immunology Dermatophagoides pteronyssinus Eosinophils - immunology Fundamental and applied biological sciences. Psychology Health. Pharmaceutical industry House dust Immune Tolerance - immunology Immunity, Cellular - immunology Immunization Immunodominant Epitopes - immunology Immunoregulation In vivo animal models Industrial applications and implications. Economical aspects Interleukin-10 - biosynthesis Interleukin-13 - biosynthesis Interleukin-4 - biosynthesis Interleukin-5 - biosynthesis Leukocyte Count Lung - cytology Lymphocytes Mice Mice, Inbred C57BL Microencapsulated antigen Peptides Peptides - immunology Population Production of active biomolecules Pulmonary Eosinophilia - immunology Pulmonary Eosinophilia - metabolism Pulmonary Eosinophilia - prevention & control Rodents Studies Th1 Cells - immunology Th2 Cells - immunology Vaccins |
title | Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A40%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20of%20allergen%20reactive%20Th2%20mediated%20responses%20and%20pulmonary%20eosinophilia%20by%20intranasal%20administration%20of%20an%20immunodominant%20peptide%20is%20linked%20to%20IL-10%20production&rft.jtitle=Vaccine&rft.au=Hall,%20Gillian&rft.date=2003-01-17&rft.volume=21&rft.issue=5&rft.spage=549&rft.epage=561&rft.pages=549-561&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/S0264-410X(02)00394-8&rft_dat=%3Cproquest_cross%3E3187691551%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c549t-3713efe42013cef6a2ad67d2f6bbede0dd09985638bf44d6c0fc25c167abb1f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490972953&rft_id=info:pmid/12531655&rfr_iscdi=true |